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Abstract. A diffuse imaging method is presented that enables wide-field estimation of the depth of fluorescent
molecular markers in turbid media by quantifying the deformation of the detected fluorescence spectra due to the
wavelength-dependent light attenuation by overlying tissue. This is achieved by measuring the ratio of the fluo-
rescence at two wavelengths in combination with normalization techniques based on diffuse reflectance mea-
surements to evaluate tissue attenuation variations for different depths. It is demonstrated that fluorescence
topography can be achieved up to a 5 mm depth using a near-infrared dye with millimeter depth accuracy
in turbid media having optical properties representative of normal brain tissue. Wide-field depth estimates
are made using optical technology integrated onto a commercial surgical microscope, making this approach
feasible for real-world applications. © 2015 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO.20.2.026002]
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1 Introduction
Optical techniques such as confocal and two-photon fluores-
cence microscopy yield micron-resolution images of tissue sec-
tions down to depths of a few hundred microns, beyond which
multiple light scattering causes significant blurring. For many
biomedical applications, particularly in vivo, it is often neces-
sary to compromise on the spatial resolution in order to achieve
larger fluorescence imaging depths over large (cm-scale) field
of view (FOV). One such application is fluorescence-guided
cancer surgery, using red/near-infrared (NIR) molecular
probes.1,2 In the last decade, this approach has been most highly
developed for brain tumor surgery using the optical contrast pro-
vided by protoporphyrin IX (PpIX) that is endogenously syn-
thesized in tumor cells following administration of the pro-
drug δ-aminolevulinic acid (ALA).3–7 Significant improvement
in survival has been demonstrated in patients with high-grade
glioma,7,8 even using qualitative visual assessment of the
PpIX fluorescence to identify residual tumor after white-light
resection, and we have previously reported on preclinical and
clinical techniques to quantify the absolute PpIX concentration
in the tissue at the time of surgery, using either a point probe
spectroscopy technique6,9–16 or wide-field quantitative imaging
of the tissue surface.5,17–21 In this and other clinical applications,
the ability to detect fluorescent tumor foci lying significantly
below the surface of the surgical cavity could further increase
the completeness of tumor resection to impact survival and
also improve patient safety by minimizing the need for blind
exploratory resection.8,22–24 This is the focus of the work
reported here.
There is considerable ongoing preclinical development of
novel high-specificity, molecularly targeted NIR fluorescent im-
aging agents that can eventually be translated to clinical use for
surgical guidance.25–27 The use of NIR fluorophores allows
detection of fluorescence from significant depths in tissue
due to the relatively low optical absorption above the main
hemoglobin absorption range and the reduced scattering at
these wavelengths. However, since most tissues are still highly
turbid (scattering ≫ absorption) at these wavelengths, the rapid
diffusion of the light degrades the attainable spatial resolution.
In addition, the concentration and depth of the fluorescent
sources are difficult to separate: e.g., the same detected signal
can be generated from a low fluorophore concentration close to
the tissue surface or a high concentration at depth. This is
addressed here by introducing a topographic technique to esti-
mate the fluorophore depth. The technique has been specifically
developed for ALA-PpIX fluorescence-guided brain cancer sur-
gery, but the concept can be applied to other fluorophores and
tumor sites with suitable adjustment of the wavelengths and
corresponding tissue optical properties.
Over the last two decades, several approaches have been
developed to localize fluorescent sources in vivo, especially
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for whole-body preclinical imaging using small animal models
(see Ref. 28 for a review). These include diffuse fluorescence
tomographic imaging by scanning over multiple source-detector
positions, for example by using photon time-of-flight methods
implemented in either the time or frequency domain.29–32 Other
techniques rely on time-resolved single-point detection to
retrieve the source depth based on the average photon time
of flight.33 However, data acquisition for these techniques can
be time consuming, typically requires expensive equipment,
and is very sensitive to small instrument misalignments, making
them very difficult to implement for routine surgical guidance in
critical sites such as the brain. In neurosurgery, the introduction
of novel technologies complementing the standard of care (i.e.,
neurosurgical microscope and neuronavigation unit) must be
minimally disruptive to the surgeon workflow. As a result,
instrumentation with a minimal footprint is required that can
provide surgeons with optical information within time frames
compatible with the flow of a surgical procedure (i.e., within
a few seconds). Here, we are presenting such a technique,
namely a multispectral, dual wavelength, self-normalized tech-
nique that can be seamlessly integrated onto a commercial sur-
gical microscope to provide topographic maps of fluorescent
sources down to several millimeters in tissue with ∼1 mm accu-
racy and precision.
By topographic imaging, here we mean that the depth of the
fluorescent structure that is closest to the accessible tissue sur-
face (e.g., the resection cavity) is determined. This is distinct
from fluorescence tomography where the goal is to reconstruct
the full three-dimensional fluorophore distribution in the tissue.
We have previously reported two complementary methods of
fluorescence topography, as demonstrated using PpIX as the flu-
orophore. Initially, multiple excitation wavelengths in the visible
range were used, with a common long-wavelength detection
band (>635 nm).21 The effective optical sampling depth (which
depends on the wavelength-dependent tissue optical properties)
of the fluorophore then primarily depended on the excitation
wavelengths. By ordering the resulting fluorescent images
according to the increasing penetration depth of the excitation
light and applying a threshold value to the signals, a tomo-
graphic two-dimensional depth profile was generated that
was experimentally shown to represent the top surface of the
subsurface fluorophore distribution. The depth accuracy in
brain was 0.5 mm up to a depth of about 3 mm for PpIX.
In the second method,19 the longest excitation wavelength of
PpIX (635 nm) was used and hyperspectral fluorescence images
were taken at the tissue surface. The wavelength-dependent dis-
tortion of the detected fluorescent light was shown to correlate
with the effective depth (up to >1 cm) of the fluorophore and
thereby suggested that a tomographic subsurface image could be
produced.
The present work develops this second approach further by
demonstrating that a simple ratiometric method can be used to
actually retrieve the fluorophore depth. The fact that the tech-
nique is directly integrated onto a neurosurgical microscope
and that image acquisition and processing can be achieved
within a few seconds should facilitate its translation to clinical
use. In brief, the technique relies on the observation that the log-
arithm of the ratio, Γ, of the detected fluorescence signal at the
tissue surface at two wavelengths varies linearly with the depth,
d, of a fluorescent point source in an optically turbid medium, as
experimentally demonstrated by Swartling et al.34 Our group
previously derived analytic solutions to the diffusion equation
for this situation in order to better understand the physical
















where the tissue optical properties at wavelength, λ, are charac-
terized by the diffusion coefficient
D ¼ 1
3ðμa þ μs 0Þ
; (2)







both of which are functions of the absorption coefficient, μa, and
the reduced scattering coefficient, μs 0.
35
Equation (1) is of the general form
lnðΓÞ ¼ m × dþ b; (4)
so that we hypothesize that dual-wavelength fluorescence ratio-
metric imaging can be used for topographic mapping of the
subsurface fluorophore depth from the expression
d ¼ lnðΓÞ − b
m
: (5)
Thus, the hypothesis we are making here is that the depth of
fluorescent sources can be estimated even in cases where the
distribution is not point-like, as explained and motivated in
Ref. 19. Clearly, the use of Eq. (5) to retrieve the depth
using a wide-field imaging system for every image pixel
requires making reliable estimates for m and b. In the present
work, we are introducing a normalization technique to make the
depth-retrieval independent of the intercept b and where tissue
attenuation properties are used to estimate a value for the slope
parameterm by applying either light transport models (requiring
the tissue optical properties to be known a priori) or non-model-
based techniques using measured diffuse reflectance data.
It is demonstrated that depth estimates can be obtained with
 ∼ 1 mm accuracy using Eq. (1) when the optical properties
are known a priori. Similar depth accuracy can be achieved
using a non-model-based approach, but only for a restricted sub-
set of tissue absorption and scattering values. The approach is
also limited to high-contrast fluorescent targets, i.e., where the
tissue autofluorescence is low relative to the exogenous fluoro-
phore. As we have previously demonstrated, this condition is
realized for ALA-PpIX fluorescence for a range of brain tumors,
including high-grade glioma and meningioma.13
2 Materials and Methods
2.1 Imaging System
Figure 1 shows a schematic of the hyperspectral imaging sys-
tem, which is attached to a free optical port on a commercial
neurosurgical microscope (Carl Zeiss Meditec). The microscope
has optics allowing zoom and FOV adjustment and is equipped
with a variable-intensity bright-field tungsten-halogen lamp
(white light) for surface structural imaging. The design of the
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detection system has been described elsewhere.5 In brief, it com-
prises a liquid crystal tunable filter (LCTF-VariSpec, CRi), a
650-nm long-pass filter (Chroma), and a charge-coupled device
camera (PixelFlyUSB, PCO). The detection subassembly is
attached to the side port using a custom optical adapter
(TrueTex), ensuring that the magnification and FOVof the fluo-
rescent images are consistent with what the surgeon views
through the microscope eyepieces. A long-pass filter (>5 OD
attenuation above 635 nm) blocks most of the excitation
light, while the liquid crystal tunable filter then selects the fluo-
rescence detection wavelength in 5 nm increments from 650 to
720 nm, allowing the acquisition of 14 fluorescence images at
different wavelengths. For fluorescence excitation, the light
from a 635-nm laser diode (Intense Co) with ∼270-mW maxi-
mum power is guided through a collimator and a 635 10-nm
band-pass filter (Chroma) to eliminate out-of-peak background
light. At each fluorescence detection wavelength, a diffuse
reflectance image is also acquired with the long-pass filter
removed to allow the acquisition of 14 reflectance images at
different wavelengths.
2.2 Tissue-Simulating Phantom Studies
A phantom (Fig. 1) was designed to simulate a discrete fluores-
cent tumor surrounded by tissue with minimal autofluorescence.
It comprised a 20-cm diameter black plastic cylindrical con-
tainer filled with intralipid (Patterson Veterinary Supply) for
light scattering and bovine methemoglobin (Sigma Aldrich)
for absorption, each at different concentrations to provide
a range of optical properties consistent with normal brain
tissue at 700 nm:13 μs 0 ¼ 23 cm−1 (1 part intralipid 20% to
10 parts water) for the first two phantoms and μs 0 ¼ 31 cm−1
(1.36 parts intralipid 20% to 10 parts water) for the third phan-
tom; μa ¼ 0.05 cm−1 (2 mg∕ml mHb) for the first phantom and
μa ¼ 0.07 cm−1 (2.5 mg∕ml) for the second and third phan-
toms: see Table 1.
A 1-cm diameter, 1-cm high transparent hollow inclusion
was placed at the center of the larger container described
above. The smaller inclusion was filled with a solution com-
posed of 1 μg∕ml of the fluorophore Alexa Fluor 647 (Life
Technologies) mixed with the same intralipid/methemoglobin
solutions used for the turbid medium material surrounding
the inclusion. The subsurface depth, d, to the top of the inclusion
(from the surface of the liquid) was increased in 1 mm steps until
the fluorescence signal was indistinguishable from the nonspe-
cific background (at d > 6 mm in all cases) of the residual
excitation light bleed through and intrinsic fluorescence of
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Fig. 1 (a) Schematics of the hyperspectral imaging system and the tissue-simulating phantom with a
subsurface fluorescent inclusion. (b) Fluorescence image of the AF 647-filled inclusion at 670 nm at
d ¼ 0. (c) Representative fluorescence emission spectra collected within the circled area in the top
right image for different depths, showing the measurable spectral distortions (normalized to the peak
emission value).
Table 1 Optical properties (at 670 nm in cm−1) used for the exper-
imental studies and single-point depth recovery results (all in mm)
associated with the three different techniques.


















23 2.0 −0.2 0.4 1.1 1.5 −0.4 0.7
23 2.5 −1.3 1.8 0.2 0.4 −1.0 1.5
31 2.5 −0.9 1.3 −0.5 1.1 −0.8 1.2
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time on tissue phantom properties, the experiments in this work
were conducted with a dye (Alexa Fluor 647) having more
favorable biochemical properties than PpIX (e.g., quantum
yield and photostability) but having similar spectral features
when excited with red light. The incident fluorescence excita-
tion power density was 20 mW∕cm2 over a circular FOV of
24 cm2 for a distance of 20 cm between the microscope con-
denser lens and the phantom surface. The total image acquisition
time (14 fluorescence images and 14 reflectance images) was in
all cases <10 s. In order to account for the instrument response
function of the imaging system, each reflectance image was
normalized to the corresponding image taken using a Spectralon
diffuse reflectance standard (Labsphere).
2.3 Monte Carlo Simulations
Monte Carlo simulations were performed using a plug-in devel-
oped for the GEANT4/GAMOS radiation transport model.36
The input optical properties included those used in the phantom
measurements, and additional absorption-scattering combina-
tions were included to verify that the results were valid over
a broader range of optical properties (Table 2). Each simulation
launched 108 photons in a 20-cm diameter uniform beam for
each inclusion depth and combination of optical properties.
The quantum yield of PpIX was set at 0.004, while the diffuse
reflectance measurements spanned 630 to 720 nm in 10 nm
steps. The light intensity at the surface was recorded for both
the fluorescence emission and the white-light diffuse reflec-
tance. The simulated source of fluorescence was a 5-mm thick
slab, where the depth from the top of the inclusion to the surface
ranged from 0 to 10 mm in 1 mm steps.
3 Results
3.1 Single-Point Analysis: Comparison with
Experimental Data
The average fluorescence spectra, Fλ, and diffuse reflectance
spectra, Rλ, were evaluated over a 3 × 3 pixels region of interest
close to the middle of the inclusion, as indicated by the circle in
Fig. 1(b). A MATLAB® script (MathWorks) was developed to
calculate the corresponding dual-wavelength fluorescence ratios
(DWFR) for all wavelength pairs and for each inclusion depth,





where the indices i and j are running from 1 to 14, i.e., over all
spectral bands (wavelengths) detected with the imaging system.
The DWFR at each depth, d, was then divided by the DWRF
value at d ¼ 0 mm. Using Eq. (4) and the mathematical identity
lnða∕bÞ ¼ lnðaÞ − lnðbÞ, it is seen that normalizing by the d ¼
0 mm image accomplishes three things: (1) it isolates the depth-
dependent part of the fluorescence ratio independent of the
emission spectrum of the dye, (2) it corrects for the wave-
length-dependent system response, and (3) it removes the






¼ m × d: (7)
Then, under the hypothesis that Eq. (1) captures the essential
light transport processes, the fluorophore depth can be estimated
by dividing the logarithm of the normalized DWFR in Eq. (7) by
m, which is computed as described below. However, depth
retrieval based on Eq. (7) requires that a fluorescence ratio meas-
urement be made for d ¼ 0 mm, which amounts to making a
reference measurement of the fluorophore of interest (AF 647
in the present study). In practice, this could be achieved
(e.g., during a fluorescence-guided surgery procedure) by
using a fluorescence ratio measurement made on cancer tissue
located directly on the surface of the surgical cavity.
As a result of Eq. (7), it is found that depth retrieval relies on
the ability to: (1) acquire zero-depth data (for calibration pur-
poses through normalization) corresponding to a reference
measurement made with no intervening tissue between the im-
aging system and a standard Alexa Fluor 647 fluorescence
source and (2) compute m. Table 3 summarizes the three tech-
niques investigated to compute m, including the mathematical
expressions used and the required input parameters. Each tech-
nique is now briefly described: Technique 1 (diffusion equation
solution) is diffusion model based and requires both tissue
absorption and reduced scattering coefficients to be known a
priori, with m then being directly computed using Eq. (1).
The other two techniques were designed to estimate m with a
minimum number of input parameters. For Technique 3 (non-
model based), since diffusion modeling19 and experiments34,37
have shown that m is directly related to factors responsible
for the differential tissue attenuation between λi and λj, we
used empirical combinations of the measured diffuse reflectance
values, Rλ in the bands around λi and λj as a surrogate for tissue
attenuation. Several mathematical expressions were considered
(e.g., ðRdλ1 − Rdλ2Þ∕Rdλ1, ln ðRdλ1∕Rdλ2Þx for a large range of x
values), but the simple expression shown in Table 3 gave the
most accurate predictions compared to the experimental phan-
tom results and the Monte Carlo simulations. Technique 2 is a
hybrid between Techniques 1 and 3. It is partly model based,
since it does not require prior knowledge of the tissue absorption
coefficient but does require the reduced scattering coefficient
value at 700 nm as an input parameter. As with Technique 3,
Table 2 Optical properties (at 670 nm in cm−1) used for the Monte
Carlo light transport studies and single-point depth recovery results
(all in mm) associated with the three different techniques.


















21 0.4 1.3 1.5 −1.1 1.6 −2.2 3.3
21 2.0 −0.1 0.8 −0.3 0.6 −1.8 2.7
21 4.0 −0.5 1.8 −0.1 1.5 −1.6 2.9
11 0.4 1.7 2.4 −0.8 1.1 −3.0 4.4
11 2.0 −0.2 0.7 −1.0 1.5 −3.4 4.4
11 4.0 0.0 1.1 0.1 0.9 −2.7 4.3
23 2.0 −0.2 0.6 0.8 1.9 −0.8 1.1
23 2.5 −0.3 1.0 0.8 1.9 −0.8 1.4
31 2.5 −0.4 1.8 0.8 1.8 0.4 1.1
Journal of Biomedical Optics 026002-4 February 2015 • Vol. 20(2)
Kolste et al.: Macroscopic optical imaging technique for wide-field estimation of fluorescence depth. . .
the expression shown in Table 3 for Technique 2 was found
through an optimization process. In cases where the calculation
of the parameter m requires the optical properties as input
values, the known optical properties of the tissue phantom were
used (see Sec. 2.2).
For conciseness, the results for the representative wavelength
pair 670 and 720 nm are presented here. However, Eq. (7) and
fluorescence ratio measurements were used to predict depth
using other wavelength pairs (one wavelength pair at the
time and not by using the information of several wavelength
pairs simultaneously) since the imaging system is acquiring
spectroscopic data for every camera pixel. The results for
other wavelength pairs are discussed in the Discussion section.
Figures 2 and 3 show the results (based on the three techniques
in Table 3) for two different sets of optical properties and where
depth predictions are made based on the experimental data for
a fluorescent inclusion. In Figs. 2(a) and 3(a), the points asso-
ciated with the label “Experimental” are the DWFR values com-
puted with the experimental data. Figures 2(b) and 3(b) show the
graphs of the predicted depths (dp) computed using Eq. (7) for
all three techniques as a function of true depth values (dt), i.e.,
the actual distance between the top of the fluorescent inclusion
and the surface of the bulk medium in the experimental phantom
(Fig. 1). On those graphs, the straight line is plotted for reference
and simply represents the real depth values. Figures 2(c) and
2(d) and 3(c) and (d) present the experimental errors (absolute
and relative) associated with depth predictions when compared
with the real depths. Table 1 shows the corresponding
differences between the calculated and true depths (mean and
maximum errors) for all sets of optical properties and all three
techniques.
3.2 Wide-Field Topographic Maps: Comparison with
Experimental Data
The same experimental dataset as used in Sec. 3.1 was used to
retrieve the fluorophore depth across the full FOVof the camera
using fluorescence ratio measurements for the wavelength pair
670 and 720 nm. A topographic map was produced using Eq. (7)
to predict local depth values using the three techniques in
Table 3. The reference fluorescence ratio measurement used
in the equation was the fluorescence ratio measured directly
at the center of the d ¼ 0 mm fluorescence images. For the
670 and 720-nm wavelength pair image, pixels were binned
to increase the signal to noise such that the spatial resolution
was ∼1 mm, and pixels were retained only above a fluorescence
intensity threshold corresponding to ≥ 50% of the highest inten-
sity of the 670-nm fluorescence image. In fact, pixels below this
threshold did not lead to physically meaningful depth values and
the corresponding raw spectra typically did not show the spec-
tral features of Alexa Fluor 647. Pixels with insufficient signal to
Table 3 Main characteristics of the three different techniques used to recover depth.
Technique Description Input parameters Limitations m (mm−1)
1 Diffusion equation solution μa, μs 0, infinite medium
boundary conditions










3 Non-model based None Not accurate for all sets of optical
properties
m ¼ lnðRd λ1Rd λ2 Þ
Fig. 2 Comparison of single-point estimation with the experimental
phantom measurements at 670 nm using the bulk optical properties
μa ¼ 0.05 cm−1 and μs 0 ¼ 23 cm−1: (a) Dual-wavelength fluores-
cence ratios (DWFR) as a function of the true depth dt . (b) Depth esti-
mation using the three different techniques versus the true depth, with
the line representing dp ¼ dt , where dp is the estimated depth.
(c) Error in absolute depth estimate (εd ). (d) Relative error in depth
estimate (εr ). “Experimental” points only appear in (a), which
shows the experimentally measured values for the DWFR.
Fig. 3 Comparison of single-point estimation with the experimental
phantom measurements at 670 nm using the bulk optical properties
μa ¼ 0.07 cm−1 and μs 0 ¼ 31 cm−1: (a) Dual-wavelength fluores-
cence ratios (DWFR) as a function of the true depth dt . (b) Depth esti-
mation using the three different techniques versus the true depth, with
the line representing dp ¼ dt , where dp is the estimated depth.
(c) Error in absolute depth estimate (εd ). (d) Relative error in depth
estimate (εr ). “Experimental” points only appear in (a), which
shows the experimentally measured values for the DWFR.
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noise or non dye-specific signals are represented with the color
black in Fig. 4. The figure only shows representative results for
μa ¼ 0.05 cm−1 and μs 0 ¼ 23 cm−1, but similar images were
obtained for the other optical properties considered.
3.3 Single-Point Analysis: Comparison with
Monte Carlo Data
In order to validate the experimental results and extend the range
of optical properties considered, detailed numerical simulations
were carried out over a range of tissue properties relevant
for brain imaging. For conciseness, in Figs. 5 and 6 and in
Table 2, we show only the results for the representative wave-
length pair 670 nm and 720 nm. Table 2 shows recovered depth
accuracy figures (mean, standard deviation, and maximum and
minimum errors) for all sets of optical properties considered
using the techniques in Table 3. The predictions (fluorescence
ratio and recovered depth) made with Techniques 1 and 2 verify
the Monte Carlo simulated data for all sets of optical properties.
However, we find that Technique 3 is uniquely suited for optical
properties having the lowest values of scattering.
4 Discussion
The Monte Carlo simulations (in single-point analysis mode
only) show that, for optical properties consistent with brain
tissue, Technique 1 (tissue input parameters to compute m:
absorption and reduced scattering) and Technique 2 (input tissue
parameter to compute m: reduced scattering only) are both able
to accurately recover the fluorophore depth up to 5 mm with an
average error of 1 mm, while the depth errors with Technique
3 (no tissue input parameters to compute m) were on average
1.5 mm. The single-point experimental data were consistent
with these findings. Although experimental and Monte Carlo
data were acquired for multiple wavelengths, the fluorescence
ratio results were only presented above for the wavelength
pair 670 and 720 nm. However, detailed analyses for all possible
wavelength pairs (considered one pair at the time for topo-
graphic depth recovery) led to similar conclusions, while, in
general, using both wavelengths above 700 nm resulted in larger
errors, likely due to the smaller spectroscopic changes in hemo-
globin absorption in that region. As might be expected, maxi-
mizing m and achieving the best agreement with the models
were obtained using wavelength pairs associated with the largest
relative changes in tissue optical properties. Simulations for a
slab rather than a finite-size inclusion were presented here in
order to evaluate the technique using datasets where the main
variable is depth and not the actual geometry of the fluorescent
source. However, Monte Carlo simulations were also performed
for a geometry identical to that used for the experimental work,
i.e., a cylindrical inclusion. Although the results for a cylindrical
inclusion are not presented here for conciseness, they have led to
single-point analysis results essentially identical to those





























Fig. 4 Topographic maps recovered using Eq. (7) with the three pro-
posed techniques (see Table 3) for the bulk optical properties μa ¼
0.05 cm−1 and μs 0 ¼ 23 cm−1 at 670 nm. The true depth (from dt ¼ 0
to 5 mm) of the fluorescent inclusion is indicated and the color bar
represents the recovered depths. The top row of images show the
raw measured fluorescence at 670 nm.
Fig. 5 Comparison of single-point estimation with Monte Carlo sim-
ulations for bulk optical properties μa ¼ 0.05 cm−1 and μs 0 ¼
23 cm−1: (a) Dual-wavelength fluorescence ratios (DWFR) as a func-
tion of the true depth dt . (b) Depth estimation using the three different
techniques versus the true depth, with the line representing dp ¼ dt ,
where dp is the estimated depth. (c) Error in absolute depth estimate
(εd ). (d) Relative error in depth estimate (εr ). “Monte Carlo” points only
appear in (a), which shows the simulated values for the DWFR.
Fig. 6 Comparison of single-point estimation with Monte Carlo sim-
ulations for bulk optical properties μa ¼ 0.07 cm−1 and μs 0 ¼
31 cm−1: (a) Dual-wavelength fluorescence ratios (DWFR) as a func-
tion of the true depth dt . (b) Depth estimation using the three different
techniques versus the true depth, with the line representing dp ¼ dt ,
where dp is the estimated depth. (c) Error in absolute depth estimate
(εd ). (d) Relative error in depth estimate (εr ). “Monte Carlo” points only
appear in (a), which shows the simulated values for the DWFR.
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Depth recovery based on experimental data was also topo-
graphically achieved (Fig. 4) using the full wide-field optical
datasets. In general, for all three techniques, the recovered
depth was underestimated by ∼0.8 mm and the resulting images
are not homogenous across the entire field. This may be due to
several experimental and model-related factors, including edge
effects of the inclusion such as seen on the raw fluorescence
image in Fig. 1(b). Experimental factors resulting in depth inac-
curacies might also include a slight unmixing of intralipid and
hemoglobin, possible spatial variations in the light source, sto-
chastic noise propagating into the ratiometric measurements, the
intralipid autofluorescence background and the approximations
in Eq. (1) that the fluorescence source is point-like and
embedded in an infinite, optically homogeneous diffusive
medium. Some of these inaccuracies perhaps speak more to
the difficulty of creating representative phantoms rather than
the validity of the technique. The precision of depth recovery
can be improved by (1) maximizing the signal to noise in the
single-wavelength fluorescence images and (2) ensuring that
the tissue optical properties are known with high accuracy so
that Technique 1 can be used. In addition, (3) the spectral
shape of nonspecific fluorescent sources is usually known and
could be deconvoluted from that associated with the dye of inter-
est in order to minimize the impact of tissue autofluorescence.
With the current system, wide-field data acquisition requires
<10 s for all the fluorescent source depths and tissue optical
properties considered (each time, 14 fluorescence images and
14 reflectance images are detected). While this integration
time is suboptimal for surgical applications, the critical result
shown here is that as few as two fluorescence wavelengths
are required for topographic imaging, which should reduce
the total imaging to <1 s, and potentially much lower when
using commercially available faster and more sensitive cameras.
Beyond speed and instrument simplicity, one key advantage of
this technique is that the ratio of fluorescence intensity at two
wavelengths is self-calibrating in that it decouples the molecular
information (fluorophore quantum yield, concentration, and life-
time) from the fluorophore spatial localization, as detailed in
Ref. 19. This is important because of the difficulty in diffuse
tomography to accurately reconstruct and separate optical con-
trast, spatial localization, and volume.
As mentioned in Sec 2.2, the experimental phantom results
presented here suggest that the autofluorescence of the bulk
medium surrounding the fluorescent inclusion is sufficiently
high to prevent detection for depths >6 mm. However, the
actual maximum detectable depth of the proposed technique
when using ALA-PpIX for surgical guidance will be sub-
sequently determined in the scope of a clinical study where
the technique is used for glioma patients. As previously
reported,6,13 the signal-to-background ratio for ALA-PpIX
guided brain surgery, at least for high-grade glioma and menin-
gioma, is high enough that the impact of tissue autofluorescence
should be negligible. However, for cases where the concentra-
tions of PpIX are much smaller (possibly in the diffusely cancer-
infiltrated boundaries of the tumor that are undetectable with the
existing technologies), it may be necessary to properly subtract
the autofluorescence background from the PpIX signals, and
thus increase the maximum detectable depth. A technique
using a spectral unmixing algorithm to separate the spectral con-
tribution of autofluorescence from that of the fluorophore of
interest is currently being developed by our group. We are
also pursuing the use of hyperspectral spatial light modulation
imaging18 in order to map the tissue optical properties to retrieve
tissue optical properties for every imaging pixel in real time.
These optical properties will be used to compute m using the
analytic expression in Eq. (1)—and retrieve depth using
Eq. (7). We and other groups26,27 are also actively investigating
fluorophores at longer NIR wavelengths in order to increase the
effective depth of subsurface fluorophore detection, so it can be
expected that the current depth limit with PpIX can be further
improved. However, the requirement for tumor specificity of the
fluorescent probe remains and it may be difficult to improve on
or even match that of ALA-PpIX.
As demonstrated here, an approach to estimating the depth of
subsurface fluorescence has been directly implemented on
a commercial neurosurgical microscope, making it suitable
for clinical application. This is in contradiction to other optical
tomography techniques that may be difficult to seamlessly inte-
grate into the neurosurgical workflow because they are relying,
e.g., on raster-scanning techniques and are often based on data
types extracted from frequency-modulated and time-resolved
signals. The simplicity of the proposed approach is that it relies
on the acquisition of wide-field continuous-wave images at
two different wavelengths. As a result, data acquisition with our
technique can be more rapid (compared to other optical tomog-
raphy techniques) since only two planar fluorescence images are
required to provide depth values with minimal data processing
time. In fact, the data processing required to obtain pixelized
depth values can be almost instantaneous and does not require,
e.g., the creation of a finite-elements mesh and the
reconstruction of images based on the resolution of an inverse
problem. However, the disadvantage of our topography tech-
nique is that the resulting depth estimates might be less precise
as those that would be obtained using an epi-illumination
tomography technique, especially close to the edges of the
sources of optical contrast where the use of multiple projections
could be required in order to more accurately localize fluores-
cent objects. It should be noted that providing neurosurgeons
with even an approximate depth of tumor lying below the sur-
face of the resection bed is critical to enable maximal safe resec-
tion in order to improve patient outcomes, since even small
amounts of residual tumor can have a marked impact on the effi-
cacy of adjuvant therapies and consequent survival.7,8 In fact,
even the dichotomic information of whether or not the informa-
tion relating to a source of fluorescence is on the surface or
underneath the surface would be of high value to neurosurgeons.
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